National Health Investors Inc
$ 88.13
-0.94%
25 Feb - close price
- Market Cap 4,198,381,000 USD
- Current Price $ 88.13
- High / Low $ 88.97 / 87.13
- Stock P/E 27.98
- Book Value 33.73
- EPS 3.15
- Next Earning Report 2026-02-26
- Dividend Per Share $3.62
- Dividend Yield 4.07 %
- Next Dividend Date -
- ROA 0.05 %
- ROE 0.11 %
- 52 Week High 91.38
- 52 Week Low 64.03
About
Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in the sale and leaseback, joint ventures, mortgages, and interim financing of discretionary and medical-based home and investment investments. in needs.
Analyst Target Price
$85.62
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-02-26 | 2025-11-06 | 2025-08-06 | 2025-05-05 | 2025-02-18 | 2024-11-05 | 2024-08-06 | 2024-05-06 | 2024-02-20 | 2023-11-07 | 2023-08-08 | 2023-05-09 |
| Reported EPS | 0 | 0.69 | 0.79 | 0.7436 | 0.8133 | 0.65 | 0.81 | 0.71 | 0.74 | 0.68 | 0.92 | 0.79 |
| Estimated EPS | 0.7882 | 0.6504 | 0.7526 | 0.7086 | 0.7514 | 0.73 | 0.74 | 0.68 | 0.68 | 0.72 | 0.69 | 0.85 |
| Surprise | -0.7882 | 0.0396 | 0.0374 | 0.035 | 0.0619 | -0.08 | 0.07 | 0.03 | 0.06 | -0.04 | 0.23 | -0.06 |
| Surprise Percentage | -100% | 6.0886% | 4.9694% | 4.9393% | 8.238% | -10.9589% | 9.4595% | 4.4118% | 8.8235% | -5.5556% | 33.3333% | -7.0588% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-26 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 1.23 |
| Currency | USD |
Previous Dividend Records
| Jan 2026 | Oct 2025 | Aug 2025 | May 2025 | Jan 2025 | Nov 2024 | Aug 2024 | May 2024 | Jan 2024 | Nov 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-01-30 | 2025-10-31 | 2025-08-01 | 2025-05-02 | 2025-01-29 | 2024-11-01 | 2024-08-02 | 2024-05-03 | 2024-01-26 | 2023-11-03 |
| Amount | $0.92 | $0.92 | $0.9 | $0.9 | $0.9 | $0.9 | $0.9 | $0.9 | $0.9 | $0.9 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: NHI
2026-02-25 06:53:15
National Health Investors (NHI) recently appointed Lilly H. Donohue, former CEO of Holiday Retirement, to its Board of Directors, bringing extensive senior housing operating experience. This addition is expected to influence NHI's senior housing operating portfolio and growth strategies, though it doesn't immediately alter near-term occupancy risks. Investors will closely watch NHI's upcoming Q4 2025 earnings report for updates on SHOP performance and occupancy.
2026-02-23 21:15:17
National Health Investors (NYSE:NHI) has appointed Lilly H. Donohue to its Board of Directors, effective February 17, 2026. Donohue, currently President and CEO of Everstory Partners and former CEO of Holiday Retirement, brings extensive experience in senior housing operations, international expansion, and financial management from her past roles at Fortress Investment Group and BlackRock. Her appointment is expected to significantly contribute to NHI's organic and external growth strategies.
2026-02-22 10:48:50
Jupiter Asset Management Ltd. recently acquired 22,262 shares of National Health Investors (NYSE: NHI) in the third quarter, valued at approximately $1.77 million, contributing to institutional investors owning about 62.51% of the stock. NHI shares are currently trading near their 52-week high, with a market capitalization of $4.22 billion. The company holds a consensus "Moderate Buy" rating from analysts with an average price target of $85.57.
2026-02-22 10:39:50
JPMorgan Chase & Co. increased its stake in National Health Investors, Inc. (NHI) by 34.0% in the third quarter, now owning 1,613,051 shares valued at approximately $128.24 million, representing about 3.39% of the company. Other institutional investors also adjusted their holdings. The stock currently holds a "Moderate Buy" consensus rating from analysts with an average price target of $85.57.
2026-02-22 09:50:08
Bowen Hanes & Co. Inc. increased its stake in National Health Investors, Inc. (NYSE:NHI) by 30% in the third quarter, bringing its total holding to 260,000 shares valued at approximately $20.67 million. Several other institutional investors also increased their positions, with institutional investors now owning 62.51% of the company's stock. Analysts currently have a "Moderate Buy" consensus rating for NHI, with a target price of $85.57, while the stock last opened at $88.59.
2026-02-20 13:52:54
National Health Investors, Inc. (NYSE:NHI) has received a consensus "Moderate Buy" rating from seven analysts, with an average one-year target price of $85.57. Institutional investors have also shown increased interest, with major firms like Vanguard Group and JPMorgan Chase & Co. significantly boosting their holdings. The company, a specialized REIT focusing on healthcare and senior housing facilities, currently trades at $88.74, boasting a market cap of $4.23 billion.
